Strategic Diversity, Inc. v. Alchemix Corporation

CourtCourt of Appeals for the Ninth Circuit
DecidedDecember 2, 2011
Docket10-15256
StatusPublished

This text of Strategic Diversity, Inc. v. Alchemix Corporation (Strategic Diversity, Inc. v. Alchemix Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Strategic Diversity, Inc. v. Alchemix Corporation, (9th Cir. 2011).

Opinion

FOR PUBLICATION UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT

STRATEGIC DIVERSITY, INC., a  Massachusetts corporation and KENNETH P. WEISS, an unmarried man, Plaintiffs-Appellants, Nos. 10-15256 v. 10-16404 ALCHEMIX CORPORATION, an  D.C. No. Arizona corporation; ROBERT R. 2:07-cv-00929-GMS HORTON, husband; CHERYL HALOTA OPINION HORTON, wife; MEDICI ASSOCIATES, LLC, a Delaware limited liability company, Defendants-Appellees.  Appeal from the United States District Court for the District of Arizona G. Murray Snow, District Judge, Presiding

Argued and Submitted July 20, 2011—San Francisco, California

Filed December 2, 2011

Before: Procter Hug, Jr. and Johnnie B. Rawlinson, Circuit Judges, and Jed S. Rakoff, Senior District Judge.*

Opinion by Judge Hug; Concurrence by Judge Rawlinson

*The Honorable Jed S. Rakoff, Senior District Judge for the U.S. Dis- trict Court for Southern New York, sitting by designation.

20613 STRATEGIC DIVERSITY v. ALCHEMIX CORP. 20617

COUNSEL

James O. Ehinger, Jennings, Strouss & Salmon, P.L.C., Phoe- nix, Arizona, for the appellants.

Stephen W. Tully, Gordon & Rees LLP, Phoenix, Arizona, for the appellees.

OPINION

HUG, Senior Circuit Judge:

This appeal concerns the maintenance of a suit for rescis- sion under section 10(b) of the Securities and Exchange Act of 1934 by plaintiffs-appellants Kenneth Weiss and his wholly-owned corporation Strategic Diversity, Inc. The dis- trict court granted summary judgment to defendants-appellees Robert Horton, Alchemix Corporation, and Medici Associates on all claims and awarded the defendants attorneys’ fees. We affirm in part, reverse in part, vacate the attorneys’ fee award, and remand.

I. Background

A. The Initial Investment

In April 2001, Kenneth P. Weiss met Robert Horton. Weiss expressed interest in investing in Horton’s alternative fuels 20618 STRATEGIC DIVERSITY v. ALCHEMIX CORP. start-up company, Alchemix Corporation. At the direction of his accountant, Weiss set up Strategic Diversity, Inc., (“Strategic”) to handle his investments. In Strategic’s first venture, Weiss sought to invest $500,000 in Alchemix and requested certain collateral to secure his investment. Approxi- mately two weeks later, the parties arrived at an agreement.

In a seven-page agreement signed on July 2, 2001, Strate- gic agreed to invest $500,000 in Alchemix. The agreement incorporated the following: (1) a convertible promissory note (“Note”) in the amount of $500,000.00; (2) security interests in Alchemix’s patents and intellectual property rights; and (3) a warrant which included a provision that ensured capitaliza- tion of the company could not exceed 40 million shares (“Warrant”).

The Note was to be paid after five years at an interest rate of ten percent per year compounded monthly. Under the terms of the Note, Weiss had the option of converting the Note to 250,000 shares of stock at a price of $2 or such price as offered to other investors. Alchemix had the ability to prepay the Note after one year if three conditions were met: (1) Alchemix had to give Strategic 30 days advance written notice; (2) Alchemix had to pay a prepayment penalty of $10,000; and (3) during the 30 day notice period, Alchemix had to give Strategic the option to convert the Note into 250,000 shares of Alchemix stock at $2 per share or any lower price offered to other investors.

While the agreement did not guarantee Weiss a seat on the Board, it stated that Alchemix “shall immediately undertake its best efforts . . . to elect Weiss . . . and retain [him] in such Board position at least until such time as the [Note] . . . [has] been satisfied or converted pursuant to the terms delineated therein.” Weiss obtained his seat on the Board shortly after his investment was made. STRATEGIC DIVERSITY v. ALCHEMIX CORP. 20619 As part of the loan, Weiss also obtained secured interests in Alchemix’s property in certain patents and protection in the form of anti-dilution provisions.

B. Alchemix Needs Further Investment

In May 2002, Alchemix needed money. To that end, Alchemix entered into negotiations with the Alchemix Fund- ing Group (“AFG”). AFG was an investment group indepen- dent of Alchemix, but the group included members of Alchemix’s Board. Horton claims that Weiss was a member of AFG, but Weiss denies this assertion.

Throughout the month, AFG and Alchemix negotiated the terms of an agreement. AFG would loan Alchemix approxi- mately $3 million, but it required certain terms on its loan. Those terms, however, conflicted with Strategic’s then-held rights. To get the loan from AFG, Alchemix (and AFG) would need Strategic to make concessions. Weiss testified that his goal was to see that Alchemix succeed, and he believed that securing this line of funding would help Alchemix. Weiss agreed to make certain concessions; how- ever, not surprisingly, he sought to be compensated for them. He negotiated with Alchemix and AFG to find an acceptable outcome for all.

The negotiations culminated in a June 5, 2002 letter from Strategic to Alchemix. In that letter, Weiss, on behalf of Stra- tegic, wrote that he understood Alchemix was seeking fund- ing from AFG in the amount of three million dollars. He indicated that he intended to be an investor in AFG and that his agreement to waive Strategic’s rights was “contingent upon my investment in [AFG].” Weiss then noted that he would agree to waive Strategic’s rights on certain terms. Spe- cifically, he stood ready to waive anti-dilution provisions, increase the amount of capitalized shares, and release his security interests in Alchemix patents in exchange for a 20620 STRATEGIC DIVERSITY v. ALCHEMIX CORP. $250,000 investment in Alchemix (500,000 shares at $0.50 per share).

As part of the proposed AFG loan agreement, AFG was to initially supply $1.5 million to Alchemix. A portion of that money, $560,000, was to be paid to Strategic in order to remove Strategic’s security interests in Alchemix property. Once collateral requirements were in order, AFG would sup- ply another $1.8 million, bringing its total investment in Alchemix to $3.3 million.

C. Western Oil Sands

However, the AFG-Alchemix transaction never took place because in the midst of those negotiations, Horton received welcome news for Alchemix. On June 17, 2002, a Canadian company, Western Oil Sands (“Western”), indicated its inter- est in a potentially larger investment in Alchemix than AFG was willing to offer. Western sent a “Memorandum of Under- standing” (“Western Memo”) to Horton. According to the Western Memo, Western was to make an initial investment of $3 million and had the option to continue investment if certain conditions were met. The potential investment was up to $36 million.

The next day, on June 18, 2002, Horton canceled the nego- tiations with AFG. He faxed a copy of the Western Memo to members of the Alchemix Board, including Weiss who received the document.

Sometime after the Western proposal and the circulated Western Memo, Weiss asserts that Horton misrepresented the nature of the Western investment. Weiss testified that he and Horton were “on the phone fairly often” and that “Bob Horton told me that they [Western] were investing $30 million and that the various concessions that I made were, from my per- sonal point of view, contingent on and related directly to that kind of investment.” Weiss also claims that he inquired as to STRATEGIC DIVERSITY v. ALCHEMIX CORP. 20621 whether there were “any adverse facts or circumstances” that would affect his decision and that Horton did not offer any comments.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Merck & Co. v. Reynolds
559 U.S. 633 (Supreme Court, 2010)
Affiliated Ute Citizens of Utah v. United States
406 U.S. 128 (Supreme Court, 1972)
TSC Industries, Inc. v. Northway, Inc.
426 U.S. 438 (Supreme Court, 1976)
Randall v. Loftsgaarden
478 U.S. 647 (Supreme Court, 1986)
Basic Inc. v. Levinson
485 U.S. 224 (Supreme Court, 1988)
Dura Pharmaceuticals, Inc. v. Broudo
544 U.S. 336 (Supreme Court, 2005)
Betz v. Trainer Wortham & Co., Inc.
610 F.3d 1169 (Ninth Circuit, 2010)
Russell Johnson, Iii v. Lucent Technologies Inc.
653 F.3d 1000 (Ninth Circuit, 2011)
Watts v. Hogan
534 P.2d 741 (Arizona Supreme Court, 1975)
Standard Chartered PLC v. Price Waterhouse
945 P.2d 317 (Court of Appeals of Arizona, 1997)
Aaron v. Fromkin
994 P.2d 1039 (Court of Appeals of Arizona, 2000)
Staheli v. Kauffman
595 P.2d 172 (Arizona Supreme Court, 1979)
State v. Superior Court of Maricopa County
599 P.2d 777 (Arizona Supreme Court, 1979)
Lundy v. Airtouch Communications, Inc.
81 F. Supp. 2d 962 (D. Arizona, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
Strategic Diversity, Inc. v. Alchemix Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/strategic-diversity-inc-v-alchemix-corporation-ca9-2011.